[Research and development strategy of anti-atrial fibrillation agents].
Hashimoto
Yoshihiro
Y
hashimoto.yoshihiro@mp.mt-pharma.co.jp
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D002544:Cerebral Infarction / Q000209:etiology / Q000517:prevention & control; D015195:Drug Design; D006801:Humans; D007473:Ion Channels / Q000037:antagonists & inhibitors
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D007473:Ion Channels